Company Filing History:
Years Active: 2003-2012
Title: Innovations by Elizabeth Messersmith
Introduction
Elizabeth Messersmith is a prominent inventor based in El Cerrito, California. She has made significant contributions to the field of medical research, particularly in the treatment of liquid tumors and rheumatoid arthritis. With a total of four patents to her name, her work has the potential to impact many lives.
Latest Patents
Among her latest patents, one focuses on methods and compositions for treating liquid tumors. This application relates to a method of using compositions that have anti-alpha-4 integrin and/or anti-alpha-9 integrin activity to inhibit liquid tumor growth and the development of metastases. Additionally, she has developed pharmaceutical compositions and combination therapies that work alongside chemotherapies to enhance treatment efficacy. Another notable patent addresses methods and compositions for treating rheumatoid arthritis. This application involves administering a combination therapy that includes methotrexate and an antibody to alpha-4 integrin, or an immunologically active antigen binding fragment. The invention also covers methods of preparing these compounds and their therapeutic applications.
Career Highlights
Elizabeth Messersmith is currently associated with Elan Pharmaceuticals, Inc., where she continues to innovate and contribute to the field of pharmaceuticals. Her work is characterized by a strong focus on developing effective treatments for serious medical conditions.
Collaborations
Some of her notable coworkers include Theodore A. Yednock and Michael A. Pleiss, who have collaborated with her on various projects and research initiatives.
Conclusion
Elizabeth Messersmith's contributions to medical research through her patents demonstrate her commitment to improving healthcare outcomes. Her innovative approaches to treating liquid tumors and rheumatoid arthritis highlight the importance of ongoing research and development in the pharmaceutical industry.